We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Grey today

18 July 2007 By Robert Cyran

The US drug giant s sales were expected to tread water until 2009, when Lipitor loses patent protection and the real pain starts. But its hard times might be starting three years early. Sales of the $13bnayear cardiovascular drug are now being hit by competitors.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)